Evolent Health, Inc. Quarterly Debt-to-equity in % from Q1 2016 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Evolent Health, Inc. quarterly Debt-to-equity history and growth rate from Q1 2016 to Q3 2024.
Evolent Health, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 127 %, a 5.56% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	127	+6.71	+5.56%	Sep 30, 2024
Q2 2024	129	+13.1	+11.3%	Jun 30, 2024
Q1 2024	131	+19.2	+17.2%	Mar 31, 2024
Q4 2023	126	+14.3	+12.8%	Dec 31, 2023
Q3 2023	121	+10.8	+9.87%	Sep 30, 2023
Q2 2023	115	+4.97	+4.5%	Jun 30, 2023
Q1 2023	112	+1.56	+1.42%	Mar 31, 2023
Q4 2022	112	+3.4	+3.14%	Dec 31, 2022
Q3 2022	110	-2.63	-2.34%	Sep 30, 2022
Q2 2022	111	-4.64	-4.03%	Jun 30, 2022
Q1 2022	110	-1.43	-1.28%	Mar 31, 2022
Q4 2021	108	+9.16	+9.25%	Dec 31, 2021
Q3 2021	112	+29.5	+35.6%	Sep 30, 2021
Q2 2021	115	+47.6	+70.5%	Jun 30, 2021
Q1 2021	111	+55	+97.3%	Mar 31, 2021
Q4 2020	99	+48.8	+97.2%	Dec 31, 2020
Q3 2020	83	+36	+76.5%	Sep 30, 2020
Q2 2020	67.6	+27	+66.4%	Jun 30, 2020
Q1 2020	56.5	+20.5	+56.9%	Mar 31, 2020
Q4 2019	50.2	+19.1	+61.2%	Dec 31, 2019
Q3 2019	47	+21.3	+82.9%	Sep 30, 2019
Q2 2019	40.6	+15.5	+62%	Jun 30, 2019
Q1 2019	36	+10.5	+40.9%	Mar 31, 2019
Q4 2018	31.1	+3.37	+12.1%	Dec 31, 2018
Q3 2018	25.7	-5.29	-17.1%	Sep 30, 2018
Q2 2018	25.1	-5.57	-18.2%	Jun 30, 2018
Q1 2018	25.6	-2.71	-9.59%	Mar 31, 2018
Q4 2017	27.8	+4.54	+19.5%	Dec 31, 2017
Q3 2017	31	+16.2	+110%	Sep 30, 2017
Q2 2017	30.6	+15.2	+98.5%	Jun 30, 2017
Q1 2017	28.3	+13.3	+88.8%	Mar 31, 2017
Q4 2016	23.2			Dec 31, 2016
Q3 2016	14.8			Sep 30, 2016
Q2 2016	15.4			Jun 30, 2016
Q1 2016	15			Mar 31, 2016

* An asterisk sign (*) next to the value indicates that the value is likely invalid.